Literature DB >> 21934596

Clinical features of patients with recurrent invasive Streptococcus pneumoniae disease.

Maurice A Mufson1, Jenelle B Hao, Ronald J Stanek, Nancy B Norton.   

Abstract

INTRODUCTION: Invasive Streptococcus pneumoniae (pneumococcal) disease (IPD) carries a high risk of death, approximately 15% to 20% in pneumonia, 40% in meningitis and 10% to 15% in septicemia. The occurrence of 2 or more IPD (recurrent) in the same individual is uncommon. The authors investigated the clinical features of patients with recurrent IPD to assess whether they possessed risk factors that increased their likelihood of recurrent IPD.
METHODS: Between 1983 and 2010, the authors identified 27 patients with recurrent IPD during inpatient surveillance of 889 patients with IPD in Huntington, WV, by recovery of pneumococci from otherwise sterile sites. Serotype/serogroup (ST/SG) was determined by capsular swelling and the penicillin MIC by E-strip. Clinical data were abstracted from hospital charts.
RESULTS: Sixteen (59%) of 27 patients were 65 years and older at first IPD, males predominated (67%), two-thirds had pneumonia and 21 (78%) had the same clinical diagnosis at both IPD. Four (80%) of 5 patients with the same ST experienced their second IPD 1 to 6 months apart, unlike most patients with discordant ST/SGs (P = 0.047). Eighty-four percent of ST/SGs were included in the 23-valent pneumococcal vaccine and occurred as often during the first and second IPD. Twenty (77%) of 26 adults suffered from comorbid diseases placing them at high risk of IPD, including multiple myeloma, HIV/AIDS, neoplasia of hematological origin and sickle cell disease.
CONCLUSIONS: Recurrent IPD occurred uncommonly. Comorbid conditions including multiple myeloma and immunosuppressive/immunodeficient conditions, chronic alcoholism and splenectomy represented unique risk factors for recurrent IPD but did not predict recurrences.

Entities:  

Mesh:

Year:  2012        PMID: 21934596     DOI: 10.1097/MAJ.0b013e31822d9860

Source DB:  PubMed          Journal:  Am J Med Sci        ISSN: 0002-9629            Impact factor:   2.378


  8 in total

1.  Streptococcus pneumoniae bacteraemia leading to the diagnosis of multiple myeloma.

Authors:  Savita Shahani; Lokesh Shahani
Journal:  BMJ Case Rep       Date:  2014-09-19

2.  Recurrent pneumococcal invasive disease in the region of Madrid during a five-year period.

Authors:  J C Sanz; I Rodríguez-Avial; E Ríos; B Ramos; E Cercenado
Journal:  Infection       Date:  2013-12-22       Impact factor: 3.553

Review 3.  Integrative Physiology of Pneumonia.

Authors:  Lee J Quinton; Allan J Walkey; Joseph P Mizgerd
Journal:  Physiol Rev       Date:  2018-07-01       Impact factor: 37.312

4.  Recurrent invasive pneumococcal disease in children: underlying clinical conditions, and immunological and microbiological characteristics.

Authors:  Laia Alsina; Maria G Basteiro; Hector D de Paz; Melania Iñigo; Mariona F de Sevilla; Miriam Triviño; Manel Juan; Carmen Muñoz-Almagro
Journal:  PLoS One       Date:  2015-03-04       Impact factor: 3.240

5.  Epidemiology of invasive pneumococcal infections: manifestations, incidence and case fatality rate correlated to age, gender and risk factors.

Authors:  Erik Backhaus; Stefan Berg; Rune Andersson; Gunilla Ockborn; Petter Malmström; Mats Dahl; Salmir Nasic; Birger Trollfors
Journal:  BMC Infect Dis       Date:  2016-08-03       Impact factor: 3.090

6.  Fluoroquinolone treatment as a protective factor for 10-day mortality in Streptococcus pneumoniae bacteremia in cancer patients.

Authors:  Naihma Salum Fontana; Karim Yaqub Ibrahim; P R Bonazzi; F Rossi; S C G Almeida; F M Tengan; M C C Brandileone; E Abdala
Journal:  Sci Rep       Date:  2021-02-12       Impact factor: 4.379

7.  Intravenous Immunoglobulin for Overwhelming Postsplenectomy Infection.

Authors:  Kensuke Nakamura; Yuji Takahashi; Tomohiro Sonoo; Hideki Hashimoto
Journal:  J Glob Infect Dis       Date:  2021-01-29

8.  Clinical Presentations and Outcomes of Children in Canada With Recurrent Invasive Pneumococcal Disease From the IMPACT Surveillance Network.

Authors:  Yousif Murad; Te-Yu Hung; Manish Sadarangani; Shaun K Morris; Nicole Le Saux; Otto G Vanderkooi; James D Kellner; Gregory J Tyrrell; Irene Martin; Walter Demczuk; Scott A Halperin; Julie A Bettinger; N Bridger; Cheryl Foo; S A Halperin; K A Top; R Thibeault; D Moore; J Papenburg; M Lebel; N Le Saux; S Morris; J Embree; B Tan; Athena McConnell; T Jadavji; C Constantinescu; W Vaudry; D Scheifele; M Sadarangani; J Bettinger; L Sauvé
Journal:  Pediatr Infect Dis J       Date:  2022-04-01       Impact factor: 3.806

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.